Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep837 | Thyroid cancer | ECE2015

Comparable ablation outcome between second and third ablation doses of 30 mCi radioactive iodine (131I) in patients with papillary thyroid cancer

Salman Khaled , Zatary Safwan , Wagieh Shereen , Abd-El Kareem Maha , Mohammad Yasser , Abd-El Razek Sherif , Al-Ezzi Manal

Introduction: Complete ablation of residual thyroid tissue in patients with papillary thyroid cancer decreases locoregional recurrence, distant metastases and cancer death. No single group achieved 100% complete ablation post first ablation dose with variable successful complete ablation rate. In patients who failed to achieve complete ablation a reablation dose is recommended to have complete ablation outcome. Post second ablation dose some patients still have small residual ...

ea0037ep1010 | Thyroid (non-cancer) | ECE2015

1 year response rate to 10 mCi radioactive iodine (I131) in patients with relapsed Graves' disease

Salman Khaled , Zatary Safwan , Wagieh Shereen , Munshy Tarek , Kareem Maha Abd-El , Mohammad Yasser , Al-Ezzi Manal

Introduction: Failure of medical treatment in patients with primary diffuse toxic goitre (GravesÂ’disease) was reported in around 50% of patients and can occur few months after cessation of therapy. Radioactive I131 therapy is a good therapeutic alternative that can be used safely in patients with relapsed GravesÂ’ disease and achieve good response rate with hypothyroisdism representing the main side effect.Aim: The...